November 2, 2016 / 12:17 AM / 2 years ago

Japan's Takeda shares halted on news of interest in Valeant assets

TOKYO, Nov 2 (Reuters) - Trading in shares of Japan’s Takeda Pharmaceutical Co was suspended in Tokyo on Wednesday after news the company was interested in buying Canadian drugmaker Valeant Pharaceuticals International Inc’s stomach-drug business.

People familiar with the matter told Reuters the deal for the sale of the Salix business could raise as much as $10 billion for Valeant.

A Takeda spokesman said the company had no immediate comment but would release a comment through the stock exchange shortly. (Reporting by Chang-Ran Kim; Editing by Richard Pullin)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below